Toxic epidermal necrolysis in Western Australia

Australasian Journal of Dermatology

Volumn 41, Issue 1, 2000, Pages 31-33

  Brand, Roland ^a   Rohr, James B ^b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b NONE

Author keywords

Corticosteroids; Drug eruption; Lyell syndrome

Indexed keywords

ALLOPURINOL; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; CORTICOSTEROID;

ADULT; AGED; ARTICLE; AUSTRALIA; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; FEMALE; HUMAN; KIDNEY FAILURE; MALE; MORTALITY; ONSET AGE; RISK FACTOR; TOXIC EPIDERMAL NECROLYSIS;

ADRENAL CORTEX HORMONES; ADULT; AGE FACTORS; AGED; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; WESTERN AUSTRALIA;

EID: 0034092802     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-0960.2000.00384.x     Document Type: Article

References (20)

1. 1. Criton S, Devik Sridevi PK, Asokan PU. Toxic epidermal necrolysis: A retrospective study. Int. J. Dermatol. 1997; 36: 923-5.
2. 2. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Roujeau JC. A clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome and erythema multiforme. Arch. Dermatol. 1993; 129: 92-6.
3. 3. Roujeau JC. The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: A clinical classification. J. Invest. Dermatol. 1994; 102: 528-30.
4. 4. Chan HL, Stern RS, Arndt RA et al. The incidence of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch. Dermatol. 1990; 126: 43-7.
5. 5. Roujea J-C, Guillaume JC, Fabre JP, Penso D, Flechet MM-L, Girre J-P. Toxic epidermal necrolysis (Lyell syndrome), incidence and drug etiology in France, 1981-85. Arch. Dermatol. 1990; 126: 37-42.
6. 6. Roukeau J-C, Chosidow O, Saiag P, Guillaume J-C. Toxic epidermal necrolysis (Lyell syndrome). J. Am. Acad. Dermatol. 1990; 23: 1039-58.
7. 7. Schopf E, Stuhmer A, Rzany B, Victor N, Zentgraf R, Kapp JF. Toxic epidermal necrolysis and Stevens-Johnson syndrome, an epidemiologic study from West Germany. Arch. Dermatol. 1991; 127: 839-42.
8. 8. Weightman W. Toxic epidermal necrolysis. Australas. J. Dermatol. 1996; 37: 167-77.
9. 9. Miyauchi H, Hosokawa H, Aheada T, Iba H, Asada Y. T-cells subsets in drug-induced toxic epidermal necrolysis: Possible pathogenic mechanisms induced by CD8-positive cells. Arch. Dermatol. 1991; 127: 851-5.
10. 10. Stawiski MA, Ross L. Toxic epidermal necrolysis and mixed histiolymphocytic lymphoma. Cutis 1981; 28: 286-9.
11. 11. Meunier P, Castalgue S, Bastie JN et al. Cutaneous reactions after treatment with 2-chlorodeoxyadenosine. Acta Derm. Venereol. 1997; 77: 412-13.
12. 12. Fournier S, Bastuji-Garin S, Mentec H et al Toxic epidermal necrolysis associated with Mycoplasma pneumoniae infection. Eur. J. Clin. Microbiol. Infect. Dis. 1995; 14: 558-9.
13. 13. Yarbrough III DR. Experience with toxic epidermal necrolysis treated in a burn centre. J. Burn Care Rehabil. 1996; 17: 30-3.
14. 14. Kim PS, Goldfarb IW, Gaisford JC. Stevens-Johnson syndrome and toxic epidermal necrolysis: A pathophysiologic review with recommendations for a treatment protocol. J. Burn Care Rehabil. 1983; 4: 91-100.
15. 15. Murphy JT, Purdue GF, Hunt JL. Toxic epidermal necrolysis. J. Burn Care Rehabil. 1997; 18: 417-20.
16. 16. Englehardt SL, Schurr MJ, Heldergon RB. Toxic epidermal necrolysis: An analysis of referral patterns and steroid usage. J. Burn Care Rehabil. 1997; 18: 520-4.
17. 17. Pasricha JS, Rhaitan BH, Shantharaman R, Mital A, Girdhar M. Toxic epidermal necrolysis. Int. J. Dermatol. 1996; 35: 523-7.
18. 18. Primka III EJ, Camisa C. Methotrexate induced toxic epidermal necrolysis in a patient with psoriasis. J. Am. Acad. Dermatol. 1997; 36: 815-18.
19. 19. Chaidemenos GC, Chrysomallis F, Sombolos K, Mourellou O, Ioannides D, Papakonstantinou M. Plasmaphoresis in toxic epidermal necrolysis. Int. J. Dermatol. 1997; 36: 218-21.
20. 20. Hewitt J, Omerod AD. Toxic epidermal necrolysis treated with cyclosporin. Clin. Exp. Dermatol. 1992; 17: 264-5.